A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.

Griveau, Amelie; Seano, Giorgio; Shelton, Samuel J; Kupp, Robert; Jahangiri, Arman; Obernier, Kirsten; Krishnan, Shanmugarajan; Lindberg, Olle R; Yuen, Tracy J; Tien, An-Chi; Sabo, Jennifer K; Wang, Nancy; Chen, Ivy; Kloepper, Jonas; Larrouquere, Louis; Ghosh, Mitrajit; Tirosh, Itay; Huillard, Emmanuelle; Alvarez-Buylla, Arturo; Oldham, Michael C; Persson, Anders I; Weiss, William A; Batchelor, Tracy T; Stemmer-Rachamimov, Anat; Suvà, Mario L; Phillips, Joanna J; Aghi, Manish K; Mehta, Shwetal; Jain, Rakesh K; Rowitch, David

View / Open Files

Accepted version (PDF, 4Mb)

Authors

Griveau, Amelie

Seano, Giorgio

Shelton, Samuel J

Kupp, Robert

Jahangiri, Arman

Obernier, Kirsten

Krishnan, Shanmugarajan

Publication Date

2018-05

Journal Title

Cancer cell

ISSN

1535-6108

Volume

Issue

Pages

874-889.e7

Language

eng

Type

Article

This Version

Physical Medium

Print-Electronic

Metadata

Show full item record

Citation

Griveau, A., Seano, G., Shelton, S. J., Kupp, R., Jahangiri, A., Obernier, K., Krishnan, S., et al. (2018). A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.. Cancer cell, 33 (5), 874-889.e7. https://doi.org/10.1016/j.ccell.2018.03.020

Keywords

Blood-Brain Barrier, Oligodendroglia, Cell Line, Tumor, Tumor Cells, Cultured, Animals, Humans, Mice, Glioma, Brain Neoplasms, Neoplasm Transplantation, Gene Expression Regulation, Neoplastic, Wnt Proteins, Tumor Microenvironment, Wnt Signaling Pathway, Bevacizumab, Oligodendrocyte Transcription Factor 2, Temozolomide

Sponsorship

MRC (MC_PC_12009)

Identifiers

External DOI: https://doi.org/10.1016/j.ccell.2018.03.020

This record's URL: https://www.repository.cam.ac.uk/handle/1810/278913

Rights

Licence:

http://www.rioxx.net/licenses/all-rights-reserved